Mediwhale
  • 소개
    • 창업 스토리
    • 닥터눈
    • 리더십
    • 연혁
  • 제품
    • 닥터눈 CVD
    • 닥터눈 CKD
    • 닥터눈 펀더스
    • 닥터눈 Age
  • 자료
    • 논문
    • 영문 뉴스
    • 국문 뉴스
  • 채용
  • 연락처
  • en_USEN
페이지 선택

Validation of deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from US AREDS

11월 16, 2022 | AHA Scientific Session Abstract

AHA Scientific Session Abstract, November 2022 Background In our previous study, we developed a deep-learning-based novel cardiovascular disease (CVD) risk stratification system based on retinal photographs, Reti-CVD. This study aims to further validate Reti-CVD in...

Validation of a deep-learning-based retinal biomarker (RetiCVD) in the prediction of cardiovascular disease: data from UK Biobank

11월 16, 2022 | AHA Scientific Session Abstract

AHA Scientific Session Abstract, November 2022 Introduction Currently in the United Kingdom, cardiovascular disease (CVD) risk assessment is based on the QRISK3 score, with a benchmark of 10% for 10-year CVD risk determining clinical intervention. Yet, effects on...

Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI

11월 16, 2022 | AHA Scientific Session Abstract

AHA Scientific Session Abstract, November 2022 Introduction The Korean Ministry of Food and Drug Safety (K-MFDS) has authorized over 110 artificial intelligence (AI)-software as medical devices (AI-SaMDs) for diagnostic purposes. Herein, we clinically validate the...
페이지 2 의 2«12

디지털 헬스케어의 미래를 함께 만들어나갑니다.

문의하기

소개

창업 스토리

닥터눈

리더십

연혁

제품

닥터눈 CVD

닥터눈 CKD

닥터눈 펀더스

닥터눈 Age

자료

논문

영문 뉴스

국문 뉴스

채용

문의

뉴스레터

소셜 미디어

  • 팔로우
  • 팔로우
  • 팔로우
  • 팔로우

Copyright © 2023 Mediwhale Inc. All rights reserved.      Privacy Policy  |  Terms of Use